KLISBio

KLISBio is a clinical-stage regenerative medicine company. We are developing several innovative technology platforms based entirely on natural silk fibroin, which allow for the creation of various solutions for endogenous tissue repair and regeneration. Silk is one of the most renowned and ancient materials used in medicine. In its raw state, silk consists of two main proteins, sericin and fibroin, with a glue-like layer of sericin coating two singular filaments of fibroin. Silk fibroin is fully biocompatible and promotes cell proliferation by also stimulating in-vivo tissue regeneration. Depending on the technology used, it provides a unique combination of outstanding biological...

Regenerative medicine,nerve repair,vascular surgery,bone graft substitutes,orthobiologics,orthopaedics,drug release,and tendons and ligaments repair

Klisbio operates in the Medical equipment manufacturing industry.

Klisbio's revenue is 11m - 100m

Klisbio has 11 - 50 employees.